Back to Research Hub
Mirum Pharmaceuticals, Inc.
MIRM
$95.48+1.90 (+2.02%)
Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases.
StreetsValue research for Mirum Pharmaceuticals, Inc. (MIRM)
Members get the full report for Mirum Pharmaceuticals, Inc.: a fair value estimate and valuation analysis, economic moat rating, growth and profitability factor grades, a bull and bear investment thesis, analyst price targets, insider and congressional trading activity, and which super investors own the stock.